This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

October 25-28, 2021
Delivered in a 100% Digital Format in EST Time Zone

Shihua Lin
Director, Bioassay Development Biopharmaceuticals Development, R&D at AstraZeneca


Shihua is a Director of Bioassay Development at AstraZeneca.  He has over 19 years’ experience in pharmaceuticals specializing in bioassay development for therapeutic biologics (mAb, bispecific, fusion protein, oncolytic virus, vaccine). Before joining AstraZeneca, he was a scientist at Teva Pharmaceuticals responsible for potency assay development and validation. During 2002 to 2011, he was a senior manager and scientist at Otsuka America Pharmaceuticals, where he was responsible for functional gene discovery, cell therapy, and therapeutic mAb R&D. He received his PhD in Neuroscience/Cell Biology from Kyoto Institute of Technology, and postdoctoral training at Wayne State University School of Medicine.

Agenda Sessions

  • BioPhorum Session: Applying a matrix approach for potency assay development for in vivo and ex vivo gene therapies.